Beta Bionics, Inc. Common Stock Long-term Investment Intensity
Beta Bionics, Inc. Common Stock long-term investment intensity. Beta Bionics, Inc. Common Stock (BBNX) has a Long-term Investment Intensity of 15.3% as of June 2026. Long-term investments of $44.65 Million represent 15.3% of total assets of $292.39 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Beta Bionics, Inc. Common Stock (BBNX) financial obligations for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Beta Bionics, Inc. Common Stock (2025–2025)
Long-term investment intensity of Beta Bionics, Inc. Common Stock from 2025 to 2025. This chart shows how Beta Bionics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of June 2026, the intensity stands at 15.3%, reflecting long-term investments of $44.65 Million against total assets of $292.39 Million USD.
Beta Bionics, Inc. Common Stock Long-term Investment Intensity by Year (2025–2025)
Beta Bionics, Inc. Common Stock long-term investment intensity by year from 2025 to 2025. The table below presents the year-by-year Long-term Investment Intensity for Beta Bionics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see BBNX total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 13.8% | $45.43 Million | $328.74 Million | — |